ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 85 filers reported holding ADAMAS PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $14,445,000 | +16.2% | 854,745 | +12.8% | 0.00% | 0.0% |
| Q3 2016 | $12,430,000 | +16.5% | 757,473 | +7.5% | 0.00% | +50.0% |
| Q2 2016 | $10,670,000 | +25.7% | 704,737 | +20.0% | 0.00% | 0.0% |
| Q1 2016 | $8,491,000 | -38.7% | 587,187 | +20.0% | 0.00% | -33.3% |
| Q4 2015 | $13,862,000 | +220.3% | 489,489 | +89.3% | 0.00% | +200.0% |
| Q3 2015 | $4,328,000 | -37.5% | 258,561 | -2.1% | 0.00% | -50.0% |
| Q2 2015 | $6,928,000 | +400.6% | 264,231 | +234.0% | 0.00% | – |
| Q1 2015 | $1,384,000 | -0.1% | 79,120 | -0.8% | 0.00% | – |
| Q4 2014 | $1,385,000 | +16.9% | 79,737 | +25.2% | 0.00% | – |
| Q3 2014 | $1,185,000 | +0.9% | 63,665 | -0.9% | 0.00% | – |
| Q2 2014 | $1,175,000 | – | 64,272 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kerrisdale Advisers, LLC | 335,541 | $8,019,000 | 5.58% |
| Broadfin Capital, LLC | 1,135,203 | $27,131,000 | 4.23% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 370,000 | $8,832,000 | 3.44% |
| SCP Investment, LP | 200,459 | $4,791,000 | 3.16% |
| Brenner West Capital Advisors | 947,006 | $22,633,000 | 3.09% |
| Ghost Tree Capital, LLC | 325,000 | $7,766,000 | 1.57% |
| SPHERA FUNDS MANAGEMENT LTD. | 335,500 | $8,018,000 | 1.22% |
| DELTEC ASSET MANAGEMENT LLC | 220,296 | $5,265,000 | 1.05% |
| SECTORAL ASSET MANAGEMENT INC | 351,320 | $8,397,000 | 0.92% |
| Mosaic Family Wealth, LLC | 91,314 | $2,182,000 | 0.81% |